Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Clinical trial NCT06175000 · RECRUITING
Trial details
- NCT number
- NCT06175000
- Sponsor
- Providence Health & Services
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2028-09-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.